Martin-Luther-Universität Halle-Wittenberg (MLU)

University / College


Location: Halle (Saale), Germany (DE) DE

ISNI: 0000000106792801

ROR: https://ror.org/05gqaka33

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Corrigendum to “Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany” (The Breast (2020) 54 (88–95), (S0960977620301648), (10.1016/j.breast.2020.08.011)) (2021) Schneeweiss A, Ettl J, Lüftner D, Beckmann M, Belleville E, Fasching P, Fehm TN, et al. Journal article, Erratum Surveillance of patients with conjunctival melanoma in German-speaking countries: A multinational survey of the German dermatologic cooperative oncology group (2021) Wessely A, Steeb T, Berking C, Schlaak M, Heppt M, Alter M, Bayerl C, et al. Journal article Evolution and competition between chiral spin textures in nanostripes with D2d symmetry (2020) Jena J, Gobel B, Kumar V, Mertig I, Felser C, Parkin S Journal article Mapping the evidence regarding school-to-work/university transition and health inequalities among young adults: A scoping review protocol (2020) Fialho PMM, Dragano N, Reuter M, Metzendorf MI, Richter B, Hoffmann S, Diehl K, et al. Journal article, Review article Exchange-correlation functionals for band gaps of solids: benchmark, reparametrization and machine learning (2020) Borlido P, Schmidt J, Huran AW, Tran F, Marques MAL, Botti S Journal article Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany (2020) Schneeweiss A, Ettl J, Lüftner D, Beckmann M, Belleville E, Fasching P, Fehm TN, et al. Journal article CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma (2020) Friedrich M, Heimer N, Stoehr C, Steven A, Wach S, Taubert H, Hartmann A, Seliger B Journal article, Original article Intramolecular aryl-aryl coupling: Via C-F bond activation tolerant towards C-I functionality (2020) Steiner AK, Feofanov M, Amsharov K Journal article Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC (2020) Massa C, Karn T, Denkert C, Schneeweiss A, Hanusch C, Blohmer JU, Zahm DM, et al. Journal article Treatment landscape and prognosis after treatment with trastuzumab emtansine (2020) Laakmann E, Emons J, Taran FA, Janni W, Uhrig S, Overkamp F, Kolberg HC, et al. Journal article